Specialities and Expertise:Biopharma, Biotechnology, Pharmaceutical, Cardiovascular, Metabolic Disorders, Diseases, Inflammation, Immunology, Oncology, Immuno-Oncology, Antibody Drug Conjugates (ADCs), Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Antibody Research, Drug Discovery, Ebola Virus Antibody, Regeneron Genetics Center, Antibodies Development, FDA Approved Drugs, MERS (MERS-CoV) Antibody, Monoclonal Antibody Discovery, Drug Development, nCoV, Ebola Therapy, Coronavirus (COVID-19), Coronavirus (COVID-19) - Vaccines and Therapeutics, SARS-CoV-2.
Size and Minority Status
- Products and services 4
- Сommodity codes
VelocImmune creates optimized antibody drug candidates from immunized mice and produces fully human antibodies therapeutics.
VelociT technology is used for the production of fully human therapeutic T-cell receptors (TCR) against tumor and viral antigens.
Regeneron Genetics Center is an integrated large-scale genomics program that uses DNA sequencing and analysis to discover and develop drugs for the treatment of rare diseases.
Kevzara is a fully-human monoclonal antibody for rheumatoid arthritis that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor. The med is on clinical trails to combat Covid-19 coronavirus infection.
Existing Contracts 1
External Recognition 1
Locations Served 1
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.